NCT03304821
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +5 more
- Locations
-
- Emory University Hospital Atlanta, Georgia, United States
Clinical trial condition
Vascular Diseases
Explore clinical trials studying Vascular Diseases. Study availability and eligibility vary by location and protocol.
512 public trials
79 recruiting studies
Vascular Diseases trial results
NCT05963828
- Conditions
- Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +4 more
- Locations
-
- Changhai Hospital Shanghai, Shanghai Municipality, China
NCT05717296
- Conditions
- Cardiovascular Diseases, Vascular Diseases
- Locations
-
- Groupe hospitalier Paris Saint Joseph-hopital Marie Lannelongue Le Plessis-Robinson, Île-de-France Region, France
Completed
Passive Limb Movement Study
NCT05935670
- Conditions
- Brain Diseases, Cardiovascular Diseases, Central Nervous System Diseases, +8 more
- Locations
-
- Medical College of Wisconsin Milwaukee, Wisconsin, United States
NCT06020651
- Conditions
- Adenocarcinoma, Arterial Occlusive Diseases, Arteriosclerosis, +24 more
- Locations
-
- INstitut Mutualiste Montsouris Paris, France
NCT05343637
- Conditions
- Cardiovascular Diseases, Familial Primary Pulmonary Hypertension, Hypertension, +5 more
- Locations
-
- St Vincent's Hospital Darlinghurst, New South Wales, Australia
- Royal Hobart Hospital Hobart, Tasmania, Australia
- The Alfred Hospital Melbourne, Victoria, Australia
NCT03037411
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +2 more
- Locations
-
- Medizinische Universität Graz Graz, Austria
- ZOL Genk Genk, Limburg, Belgium
- Regionaal Ziekenhuis Heilig Hart Tienen Tienen, Vlaams-Brabant, Belgium
- CHU Sart Tilman Liège, Belgium
NCT03537742
- Conditions
- Cardiovascular Diseases, Vascular Diseases, Vasculopathy
- Locations
-
- Stanford University Stanford, California, United States
NCT05380453
- Conditions
- Arteritis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +18 more
- Locations
-
- Novartis Investigative Site Freiburg im Breisgau, Baden-Wurttemberg, Germany
- Novartis Investigative Site Würzburg, Bavaria, Germany
- Novartis Investigative Site Göttingen, Lower Saxony, Germany
- Novartis Investigative Site Düsseldorf, North Rhine-Westphalia, Germany
Completed
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
NCT05228470
- Conditions
- BCMA, BCMA-CD3 Bispecific, Bispecific, +23 more
- Locations
-
- Fujian Medical University Union Hospital Fuzhou, Fujian, China
- Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
- Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China